Interní Med. 2014; 16(4): 141-144

Isolated nocturnal hypertension - a new clinical entity identified from ambulatory blood pressure monitoring

prof.MUDr.Andrej Dukát, CSc., FRCP1, MUDr.Lucia Mistríková2, MUDr.Dávid Baláž1, MUDr.Peter Sabaka1, MUDr.Denisa Čelovská, Ph.D.1, doc.MUDr.Peter Gavorník, Ph.D., mim.prof.1, doc.MUDr.Ľudovít Gašpar, CSc.1
1 II. interná klinika LF UK a UNB v Bratislave
2 Východoslovenský ústav srdcových a cievnych chorôb v Košiciach

Isolated nocturnal hypertension, as the new clinical entity in the field of hypertension was described just recently. Knowledges came from

ambulatory blood pressure monitorings, mainly from epidemiologic population studies. As tight correlations to target organ damage

and cardiovascular mortality have been found, diagnosis of this clinical unit can play an important role in the future.

Keywords: arterial hypertension, ambulatory blood pressure monitoring, isolated nocturnal hypertension

Published: June 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dukát A, Mistríková L, Baláž D, Sabaka P, Čelovská D, Gavorník P, Gašpar Ľ. Isolated nocturnal hypertension - a new clinical entity identified from ambulatory blood pressure monitoring. Interní Med. 2014;16(4):141-144.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Whelton PK, Beevers DG, Sonkodi S, et al. Strategies for improvement of awareness, treatment and control of hypertension. J Hum Hypertens 2004: 8: 563-565. Go to original source... Go to PubMed...
    2. Li Y, Wang JG. Isolated Nocturnal Hypertension. Hypertension 2003: 61: 278-283. Go to original source... Go to PubMed...
    3. O´Brien H, Sheridan J, O´Malley K. Dippers and non-dippers. Lancet 1988: 2: 397-399. Go to original source... Go to PubMed...
    4. Kario K, Matsui Y, Shibasaki S, et al. for the Japan Morning Surge-1 (JMS-1) Study Group. An ß-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study. J.Hypertens 2008; 26: 1257-1265. Go to original source... Go to PubMed...
    5. Kario K, Hoshide S, Shimizu M, et al. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens 2010; 28: 1574 -1583. Go to original source... Go to PubMed...
    6. Caramori ML, Pecis M, Azevedo MJ. Increase in nocturnal blood pressure and progresion to microalbuminuria in diabetes. N Engl J Med 2003; 348: 260-264. Go to original source... Go to PubMed...
    7. Kamoi K, Miyakoshi M, Soda S, et al. Usefulness of home blood pressure measurement in the morning in 2 type diabetic patients. Diabetes Care 2002; 25: 2218-2223. Go to original source... Go to PubMed...
    8. Homolka P. Monitorování krevního tlaku v klinické praxi a biologické rytmy. Grada Publ 2010, 208s.
    9. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology. Eur. Heart J 2013: 31: 1281-1357.
    10. Li Y, Stassen JA, Lu L, et al. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese Population Study. Hypertension 2007: 50: 333-339. Go to original source... Go to PubMed...
    11. Wijkman M, Länne T, Engvall J, et al. Masked nocturnal hypertension - a novel marker of risk in type 2 diabetes.Diabetologia: 2009: 52: 1258-1264. Go to original source... Go to PubMed...
    12. Fan HQ, Li Y, Thijs L, et al. International Database on Ambulatory Blood Pressure In Relation to Cardiovascular Outcome Investigators. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010: 28: 2036-2045. Go to original source... Go to PubMed...
    13. Li LH, Li Y, Huang QF, et al. Isolated nocturnal hypertension and arterial stiffness in a Chinese Population. Blood Press Monit 2008: 13: 157-159. Go to original source... Go to PubMed...
    14. Perez-Llored S, Toblli JE, Cardinali DP, et al. Nocturnal hypertension defined by fixed cut-off limts is a better predictor of left ventricular hypertrophy than non-dipping. Int J Cardiol 2008: 127: 387-389. Go to original source... Go to PubMed...
    15. Boggia J, Li Y, Thijs L, et al. International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDA-CO) investigators. Lancet 2007: 370: 1219-1229. Go to original source... Go to PubMed...
    16. Lee SH, Kim JH, Kang MJ, et al. Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care 2011: 34: 2180-2185. Go to original source... Go to PubMed...
    17. Hoshide S, Ishikawa J, Eguchi K, et al. Masked nocturnal hypertension and target organ damage in hypertensives with well-controlled self-mea-sured home blood pressure. Hypertens Res 2007: 30: 143-149. Go to original source... Go to PubMed...
    18. Ben-Dov Z, Kark JD, Ben-Ishay D, et al. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure du ring sleep. Hypertension 2007: 49: 1235-1241. Go to original source... Go to PubMed...
    19. Tsioufis C, Andrikou I, Thomopoulos C, et al.: Increased blood pressure or nondipping profile for prediction of cardovascular outcomes. J Hum Hypertens 2011: 25: 281-293. Go to original source... Go to PubMed...
    20. Hansen TW, Li Y, Boggia J, et al. Predictive role of the nighttime blood pressure. Hypertenson 2011: 57: 3-10. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.